Slides
Page 1
22.10.2026 1 ATRIA PLCINTERIM REPORTQ3/20261 January – 30 September 2026ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria Group's profitable growth continued in January–September The Group’s net sales was4.0% higher, supported by positive sales development both in the retail trade and Foodservice customers.The Group’s EBITremained stable, with an EBIT margin of 5.3%Atria Finland’s EBIT was EUR 2.4ௗmillion lower, due to the ASF-related pork export ban. ASF is estimated to reduce Atria Finland’s EBIT for 2026 by approx. EUR 4–5 million, of which approx. EUR 2 million was realisedduring the review period.Atria Sweden’sEBIT improved by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix across various distribution channels and product categories, bolstered EBIT.Atria Denmark & Estonia’sEBIT wasEUR 0.3 million higher. •Atria continued the implementation of its TOGETHER strategy bystrengthening the convenience food business in Sweden and Finland. •Energy projects that support climate targets:•Nurmon Bioenergia Oy's biogas plant was commissioned•Nurmon Bioenergia invests to start the capture of bio-based carbon dioxide•Construction of a 200 MWh energy storage project for the convenience food factory•Cross-border collaboration continues:•Gooh! pancakes from Finland to Sweden•Poultry products from Finland to Sweden•Finnish antibiotic-free chicken products under the Maks & Mooritsbrand in Estonia•In 2026, Atria Group’s adjusted EBIT is expected to be higher than in the previous year (EUR 69.9 million).•Atria's good market position, strong brands and good customer relationships, as well as reliable industrial processes, create the conditions for the positive development of EBIT also in 2026.•The ASF outbreak in Finland and other animal disease risks, the unstable European pork and beef market, cost inflation due to the Middle East crisis, and low consumer confidence in Atria's domestic markets are risk factors that may affect EBIT for the rest of the year. Future outlookAtria has continued the determined implementation of its TOGETHER 2030 strategy. 1 2
Page 2
22.10.2026 1 ATRIA PLCINTERIM REPORTQ3/20261 January – 30 September 2026ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria Group's profitable growth continued in January–September The Group’s net sales was4.0% higher, supported by positive sales development both in the retail trade and Foodservice customers.The Group’s EBITremained stable, with an EBIT margin of 5.3%Atria Finland’s EBIT was EUR 2.4ௗmillion lower, due to the ASF-related pork export ban. ASF is estimated to reduce Atria Finland’s EBIT for 2026 by approx. EUR 4–5 million, of which approx. EUR 2 million was realisedduring the review period.Atria Sweden’sEBIT improved by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix across various distribution channels and product categories, bolstered EBIT.Atria Denmark & Estonia’sEBIT wasEUR 0.3 million higher. •Atria continued the implementation of its TOGETHER strategy bystrengthening the convenience food business in Sweden and Finland. •Energy projects that support climate targets:•Nurmon Bioenergia Oy's biogas plant was commissioned•Nurmon Bioenergia invests to start the capture of bio-based carbon dioxide•Construction of a 200 MWh energy storage project for the convenience food factory•Cross-border collaboration continues:•Gooh! pancakes from Finland to Sweden•Poultry products from Finland to Sweden•Finnish antibiotic-free chicken products under the Maks & Mooritsbrand in Estonia•In 2026, Atria Group’s adjusted EBIT is expected to be higher than in the previous year (EUR 69.9 million).•Atria's good market position, strong brands and good customer relationships, as well as reliable industrial processes, create the conditions for the positive development of EBIT also in 2026.•The ASF outbreak in Finland and other animal disease risks, the unstable European pork and beef market, cost inflation due to the Middle East crisis, and low consumer confidence in Atria's domestic markets are risk factors that may affect EBIT for the rest of the year. Future outlookAtria has continued the determined implementation of its TOGETHER 2030 strategy. 1 2
Page 3
22.10.2026 2 AFTER THE REVIEW PERIOD•Atria has completed the change negotiations concerning the Jyväskylä cattle slaughterhouse.•Atria is centralising its cattle slaughtering operations at the Kauhajoki plant and discontinuing cattle slaughtering in Jyväskylä. The decision to transfer the cutting and packing of beef to Kauhajoki was made in autumn 2025. •Centralising cattle slaughtering operations is estimated to bring Atria annual savings of approximately EUR 2 million. The decision is based on a sharper-than-expected decline in beef procurement volumes and increased market competition. By centralising beef processing in Kauhajoki, Atria improves its efficiency and strengthens the competitiveness of its beef business.Q3/2026 RESULT DEVELOPMENT IN FIGURES475.2+4.0%Net sales, EUR millionNet sales development0.67Earnings per share, EUR(EUR 0.61)25.3EBIT, EUR million(EUR 25.4 million)5.3%EBIT %(5.6%) 3 4
Page 4
22.10.2026 2 AFTER THE REVIEW PERIOD•Atria has completed the change negotiations concerning the Jyväskylä cattle slaughterhouse.•Atria is centralising its cattle slaughtering operations at the Kauhajoki plant and discontinuing cattle slaughtering in Jyväskylä. The decision to transfer the cutting and packing of beef to Kauhajoki was made in autumn 2025. •Centralising cattle slaughtering operations is estimated to bring Atria annual savings of approximately EUR 2 million. The decision is based on a sharper-than-expected decline in beef procurement volumes and increased market competition. By centralising beef processing in Kauhajoki, Atria improves its efficiency and strengthens the competitiveness of its beef business.Q3/2026 RESULT DEVELOPMENT IN FIGURES475.2+4.0%Net sales, EUR millionNet sales development0.67Earnings per share, EUR(EUR 0.61)25.3EBIT, EUR million(EUR 25.4 million)5.3%EBIT %(5.6%) 3 4
Page 5
22.10.2026 3 Q1-Q3/2026 RESULT DEVELOPMENT IN FIGURES1,406.6+5.2%Net sales, EUR millionNet sales development1.49Earnings per share, EUR(EUR 1.30)59.9EBIT, EUR million(EUR 55.9 million)4.3%EBIT %(4.2%)-10.6Free cash flow, EUR million(EUR 37.2 million)11.7%Adjusted return of equity %, rolling 12 m(10.9%)43.9%Equity ratio(31 Dec 2025: 45.7%)ATRIA GROUP’S NET SALES Q3/2026EUR million 5 6
Page 6
22.10.2026 3 Q1-Q3/2026 RESULT DEVELOPMENT IN FIGURES1,406.6+5.2%Net sales, EUR millionNet sales development1.49Earnings per share, EUR(EUR 1.30)59.9EBIT, EUR million(EUR 55.9 million)4.3%EBIT %(4.2%)-10.6Free cash flow, EUR million(EUR 37.2 million)11.7%Adjusted return of equity %, rolling 12 m(10.9%)43.9%Equity ratio(31 Dec 2025: 45.7%)ATRIA GROUP’S NET SALES Q3/2026EUR million 5 6
Page 7
22.10.2026 4 ATRIA GROUP’S NET SALES Q1-Q3/2026EUR million ATRIA GROUP’S EBIT Q3/2026EUR million 7 8
Page 8
22.10.2026 4 ATRIA GROUP’S NET SALES Q1-Q3/2026EUR million ATRIA GROUP’S EBIT Q3/2026EUR million 7 8
Page 9
22.10.2026 5 ATRIA GROUP’S EBIT Q1-Q3/2026EUR million MARKET POSITION IN THE BUSINESS AREAS•The development of Atria's product categories in the retail market by value in January-August:•Finland +4.7% •Sweden +2.7% •Estonia +3.8% •Denmark +0.5% •Atria's own brand producer share by value in the retail market in its product categories:•Finland 25.7% •Sweden 17.6% •Estonia 21.5% •Denmark 12.0% 9 10
Page 10
22.10.2026 5 ATRIA GROUP’S EBIT Q1-Q3/2026EUR million MARKET POSITION IN THE BUSINESS AREAS•The development of Atria's product categories in the retail market by value in January-August:•Finland +4.7% •Sweden +2.7% •Estonia +3.8% •Denmark +0.5% •Atria's own brand producer share by value in the retail market in its product categories:•Finland 25.7% •Sweden 17.6% •Estonia 21.5% •Denmark 12.0% 9 10
Page 11
22.10.2026 6 ATRIA FINLAND341.8+3.4%Net sales, EUR millionNet sales development5.7%EBIT %(6.6%)Q3/2026 Key Figures19.4EBIT,EUR million-2.4EBIT development,EUR millionQ1-Q3/2026 Key Figures1,024.0+5.8%Net sales, EUR millionNet sales development4.7%EBIT %(5.0%)48.0EBIT,EUR million-0.6EBIT development,EUR millionATRIA FINLAND •In July–September, net sales increased by 3.4%. •Growth was supported by positive sales development both in the retail trade and Foodservice customers as well as strong sales during the barbecue season.•Export sales were clearly lower than in the previous year, due to a ban on pork exports caused by African swine fever.•EBIT fell by EUR 2.4 million from the comparison period. EBIT was weakened particularly by the ban on pork exports and its effects, imposed due to ASF. The negative impact on the 2026 EBIT is estimated to be approximately EUR 4–5 million, of which about EUR 2 million was realised during the review period.•In January-September, net sales grew by 5.8%. •Growth was supported by good sales development in all sales channels, except for exports.•Higher prices for beef products compared with the comparison period boosted net sales. •EBIT was EUR 0.6 million lower than in the previous year. •The result was affected by the ban on pork exports due to African swine fever.•Cost pressures remained high for both our own operations and purchased services. 11 12
Page 12
22.10.2026 6 ATRIA FINLAND341.8+3.4%Net sales, EUR millionNet sales development5.7%EBIT %(6.6%)Q3/2026 Key Figures19.4EBIT,EUR million-2.4EBIT development,EUR millionQ1-Q3/2026 Key Figures1,024.0+5.8%Net sales, EUR millionNet sales development4.7%EBIT %(5.0%)48.0EBIT,EUR million-0.6EBIT development,EUR millionATRIA FINLAND •In July–September, net sales increased by 3.4%. •Growth was supported by positive sales development both in the retail trade and Foodservice customers as well as strong sales during the barbecue season.•Export sales were clearly lower than in the previous year, due to a ban on pork exports caused by African swine fever.•EBIT fell by EUR 2.4 million from the comparison period. EBIT was weakened particularly by the ban on pork exports and its effects, imposed due to ASF. The negative impact on the 2026 EBIT is estimated to be approximately EUR 4–5 million, of which about EUR 2 million was realised during the review period.•In January-September, net sales grew by 5.8%. •Growth was supported by good sales development in all sales channels, except for exports.•Higher prices for beef products compared with the comparison period boosted net sales. •EBIT was EUR 0.6 million lower than in the previous year. •The result was affected by the ban on pork exports due to African swine fever.•Cost pressures remained high for both our own operations and purchased services. 11 12
Page 13
22.10.2026 7 ASF IN FINLAND•African swine fever (ASF) has been found in wild boar in a restricted area in south-eastern Finland. •ASF is a serious viral disease of pigs and other suids. Thedisease is not transmissible to humans.•To prevent the spread of the disease, the Finnish Food Authority has established an infected zone, a core area within it, and an additional restricted zone bordering the infected zone.•The virus has not been detected on pig production farms in Finland, and biosecurity measures are being used to keep the disease out of the farms.•Atria has no contract production farms within or near thesezones. Map of the infected zone (yellow), including the core area located within it (red), and the additional restricted zone (green) ATRIA FINLAND•Based on information from Atria’s main pork export countries, Atria has assessed the impact of ASF findings on pork exports.•The annual direct profit impact for Atria Finland from lost and redirected export sales is estimated to be approximately EUR -7 million. Estimates are based on the assumptions that pork exports to countries such as China and Japan have ended, while pork sales to South Korea continue.•Atria actively seeks to find new export markets and customers for pork. In addition, the company will take measures to reduce the negative impact of declining pork sales to Asia.•It is very important that the relevant authorities and parties take all possible measures to prevent the spread of this disease and to ensure that pork from Finland can continue to be exported outside the EU in the future. If ASF spreads to a wider area or affects pig production farms, its impact on Atria may also change. 13 14
Page 14
22.10.2026 7 ASF IN FINLAND•African swine fever (ASF) has been found in wild boar in a restricted area in south-eastern Finland. •ASF is a serious viral disease of pigs and other suids. Thedisease is not transmissible to humans.•To prevent the spread of the disease, the Finnish Food Authority has established an infected zone, a core area within it, and an additional restricted zone bordering the infected zone.•The virus has not been detected on pig production farms in Finland, and biosecurity measures are being used to keep the disease out of the farms.•Atria has no contract production farms within or near thesezones. Map of the infected zone (yellow), including the core area located within it (red), and the additional restricted zone (green) ATRIA FINLAND•Based on information from Atria’s main pork export countries, Atria has assessed the impact of ASF findings on pork exports.•The annual direct profit impact for Atria Finland from lost and redirected export sales is estimated to be approximately EUR -7 million. Estimates are based on the assumptions that pork exports to countries such as China and Japan have ended, while pork sales to South Korea continue.•Atria actively seeks to find new export markets and customers for pork. In addition, the company will take measures to reduce the negative impact of declining pork sales to Asia.•It is very important that the relevant authorities and parties take all possible measures to prevent the spread of this disease and to ensure that pork from Finland can continue to be exported outside the EU in the future. If ASF spreads to a wider area or affects pig production farms, its impact on Atria may also change. 13 14
Page 15
22.10.2026 8 ATRIA FINLAND•In the summer of 2026, Atria launched an investment in a 200 MWh high-temperature energy storage at the Nurmo production plant as part of the energy solutions for the new convenience food factory under construction.•Atria’s new convenience food factory and the Kauhajoki investments progressed as planned during the review period. The new convenience food factory will be completed by the end of 2028. Havainnekuva korkealämpöenergiavarastosta ATRIA SWEDEN107.3+8.3%Net sales, EUR millionNet sales development5.6%EBIT %(3.7%)Q3/2026 Key Figures6.1EBIT,EUR million+2.4EBIT development,EUR millionQ1-Q3/2026 Key Figures306.5+4.9%Net sales, EUR millionNet sales development3.5%EBIT %(2.3%)10.6EBIT,EUR million+4.0EBIT development,EUR million 15 16
Page 16
22.10.2026 8 ATRIA FINLAND•In the summer of 2026, Atria launched an investment in a 200 MWh high-temperature energy storage at the Nurmo production plant as part of the energy solutions for the new convenience food factory under construction.•Atria’s new convenience food factory and the Kauhajoki investments progressed as planned during the review period. The new convenience food factory will be completed by the end of 2028. Havainnekuva korkealämpöenergiavarastosta ATRIA SWEDEN107.3+8.3%Net sales, EUR millionNet sales development5.6%EBIT %(3.7%)Q3/2026 Key Figures6.1EBIT,EUR million+2.4EBIT development,EUR millionQ1-Q3/2026 Key Figures306.5+4.9%Net sales, EUR millionNet sales development3.5%EBIT %(2.3%)10.6EBIT,EUR million+4.0EBIT development,EUR million 15 16
Page 17
22.10.2026 9 ATRIA SWEDEN•In July–September, net sales grew by 8.3% from the comparison period. The growth in net sales was driven by good sales development across all sales channels.•EBIT increased by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix, bolstered EBIT. •Cost pressures stemming from rising transportation and production costs caused by growing tensions in the international operating environment continued to affect profitability.•In January–September, net sales grew by 4.9% in euros and by 3.0% in the local currency.•The avian influenza outbreak in Sweden, which weakened the availability of poultry meat earlier this year, has now subsided and no longer affects the availability of poultry meat.•EBIT was strengthened by effective sales and marketing measures, as well as a favourable sales structure across the various distribution channels and product categories. ATRIA SWEDEN•In the third quarter, Atria launched several new Gooh! convenience food products for retail. The new products supported the brand’s strong market position.•The investment of approximately EUR 23ௗmillion in the production of meat products at the Sköllersta plant, launched in December 2025, is proceeding as planned in schedule. 17 18
Page 18
22.10.2026 9 ATRIA SWEDEN•In July–September, net sales grew by 8.3% from the comparison period. The growth in net sales was driven by good sales development across all sales channels.•EBIT increased by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix, bolstered EBIT. •Cost pressures stemming from rising transportation and production costs caused by growing tensions in the international operating environment continued to affect profitability.•In January–September, net sales grew by 4.9% in euros and by 3.0% in the local currency.•The avian influenza outbreak in Sweden, which weakened the availability of poultry meat earlier this year, has now subsided and no longer affects the availability of poultry meat.•EBIT was strengthened by effective sales and marketing measures, as well as a favourable sales structure across the various distribution channels and product categories. ATRIA SWEDEN•In the third quarter, Atria launched several new Gooh! convenience food products for retail. The new products supported the brand’s strong market position.•The investment of approximately EUR 23ௗmillion in the production of meat products at the Sköllersta plant, launched in December 2025, is proceeding as planned in schedule. 17 18
Page 19
22.10.2026 10 ATRIA DENMARK & ESTONIA31.7-3.2%Net sales, EUR millionNet sales development5.2%EBIT %(4.3%)Q3/2026 Key Figures1.7EBIT,EUR million+0.3EBIT development,EUR millionQ1-Q3/2026 Key Figures91.7-2.5%Net sales, EUR millionNet sales development6.4%EBIT %(4.9%)5.9EBIT,EUR million+1.2EBIT development,EUR millionATRIA DENMARK & ESTONIA•In July–September, Atria Denmark & Estonia’s net sales were 3.2% lower.•EBIT of Atria Denmark & Estonia increased by EUR 0.3 million.•Atria Estonia’s net sales and EBIT increased compared with the corresponding period last year.•The increase in Atria Estonia's net sales resulted from increased sales to retail and industrialcustomers. •The EBIT increase in Estonia was also supported by growth in sales and lower raw material prices for pork.•Atria Denmark's net sales and EBIT were lower than in the comparison period.•The volume of the cold cuts retail market in Denmark declined slightly in the third quarter, and Atria's sales volume declined more than the market.•In January–September, the net sales of Atria Denmark & Estonia were lower than in the corresponding period of the previous year due to a decrease in Atria Denmark’s net sales. EBIT increased by EUR 1.2 million.•Atria Estonia’s net sales and EBIT increased compared with the corresponding period last year.•Net sales growth was driven by strong sales to the retail trade.•The growth of Atria Estonia’s EBIT was supported by higher sales, lower raw material prices for pork, and higher animal welfare-related subsidies compared with the comparison period.•Atria Denmark’s sales to retail and Foodservice customers were lower than in the previous year. 19 20
Page 20
22.10.2026 10 ATRIA DENMARK & ESTONIA31.7-3.2%Net sales, EUR millionNet sales development5.2%EBIT %(4.3%)Q3/2026 Key Figures1.7EBIT,EUR million+0.3EBIT development,EUR millionQ1-Q3/2026 Key Figures91.7-2.5%Net sales, EUR millionNet sales development6.4%EBIT %(4.9%)5.9EBIT,EUR million+1.2EBIT development,EUR millionATRIA DENMARK & ESTONIA•In July–September, Atria Denmark & Estonia’s net sales were 3.2% lower.•EBIT of Atria Denmark & Estonia increased by EUR 0.3 million.•Atria Estonia’s net sales and EBIT increased compared with the corresponding period last year.•The increase in Atria Estonia's net sales resulted from increased sales to retail and industrialcustomers. •The EBIT increase in Estonia was also supported by growth in sales and lower raw material prices for pork.•Atria Denmark's net sales and EBIT were lower than in the comparison period.•The volume of the cold cuts retail market in Denmark declined slightly in the third quarter, and Atria's sales volume declined more than the market.•In January–September, the net sales of Atria Denmark & Estonia were lower than in the corresponding period of the previous year due to a decrease in Atria Denmark’s net sales. EBIT increased by EUR 1.2 million.•Atria Estonia’s net sales and EBIT increased compared with the corresponding period last year.•Net sales growth was driven by strong sales to the retail trade.•The growth of Atria Estonia’s EBIT was supported by higher sales, lower raw material prices for pork, and higher animal welfare-related subsidies compared with the comparison period.•Atria Denmark’s sales to retail and Foodservice customers were lower than in the previous year. 19 20
Page 21
22.10.2026 11 ATRIA DENMARK & ESTONIA•During the review period, the Maks & Moorits brand expanded into a new product category with a launch of antibiotic-free fresh chicken products made by Atria Finland. •Atria Denmark’s development efforts focused in particular on expanding the Foodservice product range and cross-border product collaborations, preparing new export products, and identifying new export market opportunities. SHORT-TERM BUSINESS RISKS•African swine fever was detected in wild boar in Finland in Vironlahti at the end of July 2026. This has restricted Atria’s pork sales abroad. Exports to China and Japan have stopped, but exports to South Korea continue as normal. Atria actively seeks to find newexport markets and customers for pork.•During the review period, uncertainty has significantly increased due to the conflict in the Middle East that started in February 2026. The conflict is particularly reflected in the energy markets and oil price development, which have a direct impact on Atria’s transport costs throughout the food supply chain. In addition, there are cost pressures on packaging materials as well as primary production, including the prices of feed components, fertilisers and fuels.•In Europe, the market price of pork is expected to remain volatile. The instability is caused by export bans resulting from African swine fever, a decline in pork exports due to Chinese import tariffs, and lower demand in Europe. •In recent years, the beef market has been unbalanced in Europe. In the first half of 2026, beef imports from South America increased, while beef exports outside the EU decreased. In addition, the increased consumer price of beef products reduced demand. For these reasons, the price of beef has fallen since the beginning of 2026. In September, the European Union announced a ban on Brazilian beef imports to Europe, adding to market instability. •The fight against cybercrime and information system disruptions requires continuous development and a proactive approach. 21 22
Page 22
22.10.2026 11 ATRIA DENMARK & ESTONIA•During the review period, the Maks & Moorits brand expanded into a new product category with a launch of antibiotic-free fresh chicken products made by Atria Finland. •Atria Denmark’s development efforts focused in particular on expanding the Foodservice product range and cross-border product collaborations, preparing new export products, and identifying new export market opportunities. SHORT-TERM BUSINESS RISKS•African swine fever was detected in wild boar in Finland in Vironlahti at the end of July 2026. This has restricted Atria’s pork sales abroad. Exports to China and Japan have stopped, but exports to South Korea continue as normal. Atria actively seeks to find newexport markets and customers for pork.•During the review period, uncertainty has significantly increased due to the conflict in the Middle East that started in February 2026. The conflict is particularly reflected in the energy markets and oil price development, which have a direct impact on Atria’s transport costs throughout the food supply chain. In addition, there are cost pressures on packaging materials as well as primary production, including the prices of feed components, fertilisers and fuels.•In Europe, the market price of pork is expected to remain volatile. The instability is caused by export bans resulting from African swine fever, a decline in pork exports due to Chinese import tariffs, and lower demand in Europe. •In recent years, the beef market has been unbalanced in Europe. In the first half of 2026, beef imports from South America increased, while beef exports outside the EU decreased. In addition, the increased consumer price of beef products reduced demand. For these reasons, the price of beef has fallen since the beginning of 2026. In September, the European Union announced a ban on Brazilian beef imports to Europe, adding to market instability. •The fight against cybercrime and information system disruptions requires continuous development and a proactive approach. 21 22
Page 23
22.10.2026 12 FINANCIAL DEVELOPMENT”We can be satisfied with the strong growth and solid year-to-date result, especially considering the immediate impact of the African swine fever outbreak detected in Finland at the end of July on Atria Finland’s exports, as well as the increased cost pressures caused by the conflict in the Middle East.”CEO Kai Gyllström”We can be satisfied with the strong growth and solid year-to-date result, especially considering the immediate impact of the African swine fever outbreak detected in Finland at the end of July on Atria Finland’s exports, as well as the increased cost pressures caused by the conflict in the Middle East.”CEO Kai GyllströmATRIA GROUP NET SALES CUMULATIVEEUR million 23 24
Page 24
22.10.2026 12 FINANCIAL DEVELOPMENT”We can be satisfied with the strong growth and solid year-to-date result, especially considering the immediate impact of the African swine fever outbreak detected in Finland at the end of July on Atria Finland’s exports, as well as the increased cost pressures caused by the conflict in the Middle East.”CEO Kai Gyllström”We can be satisfied with the strong growth and solid year-to-date result, especially considering the immediate impact of the African swine fever outbreak detected in Finland at the end of July on Atria Finland’s exports, as well as the increased cost pressures caused by the conflict in the Middle East.”CEO Kai GyllströmATRIA GROUP NET SALES CUMULATIVEEUR million 23 24
Page 25
22.10.2026 13 ATRIA GROUP ADJUSTED EBITCUMULATIVEEUR million ATRIA GROUP INCOME STATEMENTQ1-Q3Q1-Q3Q3Q320252025202620252026EUR million1,813.71,337.21,406.6457.0475.2NET SALES-1,615.8-1,189.3-1,247.9-403.6-418.6Costs of goods sold198.0148.0158.853.456.6GROSS PROFIT10.9 %11.1 %11.3 %11.7 %11.9 %% of Net sales4.53.63.62.00.7Other income-138.4-95.7-102.5-29.9-32.0Other expenses64.055.959.925.425.3EBIT3.5 %4.2 %4.3 %5.6 %5.3 %% of Net sales-10.7-8.3-6.7-2.4-2.5Finance income and costs0.20.92.00.31.0Income from joint ventures and associates53.648.655.223.423.8PROFIT BEFORE TAXES-10.0-9.9-10.6-5.3-3.7Income taxes43.638.744.618.020.1PROFIT FOR THE PERIOD 25 26
Page 26
22.10.2026 13 ATRIA GROUP ADJUSTED EBITCUMULATIVEEUR million ATRIA GROUP INCOME STATEMENTQ1-Q3Q1-Q3Q3Q320252025202620252026EUR million1,813.71,337.21,406.6457.0475.2NET SALES-1,615.8-1,189.3-1,247.9-403.6-418.6Costs of goods sold198.0148.0158.853.456.6GROSS PROFIT10.9 %11.1 %11.3 %11.7 %11.9 %% of Net sales4.53.63.62.00.7Other income-138.4-95.7-102.5-29.9-32.0Other expenses64.055.959.925.425.3EBIT3.5 %4.2 %4.3 %5.6 %5.3 %% of Net sales-10.7-8.3-6.7-2.4-2.5Finance income and costs0.20.92.00.31.0Income from joint ventures and associates53.648.655.223.423.8PROFIT BEFORE TAXES-10.0-9.9-10.6-5.3-3.7Income taxes43.638.744.618.020.1PROFIT FOR THE PERIOD 25 26
Page 27
22.10.2026 14 ATRIA GROUP KEY INDICATORSQ1-Q3Q1-Q3Q3Q320252025202620252026EUR million1,813.71,337.21,406.6457.0475.2Net sales69.955.959.925.425.3Adjusted EBIT3.9 %4.2 %4.3 %5.6 %5.3 %Adjusted EBIT, %64.055.959.925.425.3EBIT3.5 %4.2 %4.3 %5.6 %5.3 %EBIT, %1.441.301.490.610.67EPS, EUR1.611.301.490.610.67Adjusted EPS, EUR15.3215.0916.18Shareholders´ equity per share EUR11.0 %10.9 %11.7 %Adjusted return on equity (rolling 12m), %10.5 %10.5 %10.7 %Adjusted return on investment (rolling 12m), %FINANCIAL POSITION AND EQUITY RATIOQ1-Q3Q1-Q3202520252026EUR million120.067.357.6Cash flow from operating activities -50.2-30.1-68.2Cash flow from investing activities 69.837.2-10.6Free cash flow54.232.565.9Gross investments 218.7251.2286.5Net debt48.1 %56.1 %59.6 %Net gearing, %10.78.36.7Finance cost, net1.641.892.03Net debt/adjusted EBITDA45.7 %44.8 %43.9 %Equity ratio, %3.36%3.32%3.31%Average interest rate of the loan portfolio, % 27 28
Page 28
22.10.2026 14 ATRIA GROUP KEY INDICATORSQ1-Q3Q1-Q3Q3Q320252025202620252026EUR million1,813.71,337.21,406.6457.0475.2Net sales69.955.959.925.425.3Adjusted EBIT3.9 %4.2 %4.3 %5.6 %5.3 %Adjusted EBIT, %64.055.959.925.425.3EBIT3.5 %4.2 %4.3 %5.6 %5.3 %EBIT, %1.441.301.490.610.67EPS, EUR1.611.301.490.610.67Adjusted EPS, EUR15.3215.0916.18Shareholders´ equity per share EUR11.0 %10.9 %11.7 %Adjusted return on equity (rolling 12m), %10.5 %10.5 %10.7 %Adjusted return on investment (rolling 12m), %FINANCIAL POSITION AND EQUITY RATIOQ1-Q3Q1-Q3202520252026EUR million120.067.357.6Cash flow from operating activities -50.2-30.1-68.2Cash flow from investing activities 69.837.2-10.6Free cash flow54.232.565.9Gross investments 218.7251.2286.5Net debt48.1 %56.1 %59.6 %Net gearing, %10.78.36.7Finance cost, net1.641.892.03Net debt/adjusted EBITDA45.7 %44.8 %43.9 %Equity ratio, %3.36%3.32%3.31%Average interest rate of the loan portfolio, % 27 28
Page 29
22.10.2026 15 ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria Group's profitable growth continued in January–September The Group’s net sales was4.0% higher, supported by positive sales development both in the retail trade and Foodservice customers.The Group’s EBITremained stable, with an EBIT margin of 5.3%Atria Finland’s EBIT was EUR 2.4ௗmillion lower, due to the ASF-related pork export ban. ASF is estimated to reduce Atria Finland’s EBIT for 2026 by approx. EUR 4–5 million, of which approx. EUR 2 million was realisedduring the review period.Atria Sweden’sEBIT improved by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix across various distribution channels and product categories, bolstered EBIT.Atria Denmark & Estonia’sEBIT wasEUR 0.3 million higher. •Atria continued the implementation of its TOGETHER strategy bystrengthening the convenience food business in Sweden and Finland. •Energy projects that support climate targets:•Nurmon Bioenergia Oy's biogas plant was commissioned•Nurmon Bioenergia invests to start the capture of bio-based carbon dioxide•Construction of a 200 MWh energy storage project for the convenience food factory•Cross-border collaboration continues:•Gooh! pancakes from Finland to Sweden•Poultry products from Finland to Sweden•Finnish antibiotic-free chicken products under the Maks & Mooritsbrand in Estonia•In 2026, Atria Group’s adjusted EBIT is expected to be higher than in the previous year (EUR 69.9 million).•Atria's good market position, strong brands and good customer relationships, as well as reliable industrial processes, create the conditions for the positive development of EBIT also in 2026.•The ASF outbreak in Finland and other animal disease risks, the unstable European pork and beef market, cost inflation due to the Middle East crisis, and low consumer confidence in Atria's domestic markets are risk factors that may affect EBIT for the rest of the year. Future outlookAtria has continued the determined implementation of its TOGETHER 2030 strategy. THANK YOU!Financial Statement Release 2026 on 12 February 2027 29 30
Page 30
22.10.2026 15 ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria Group's profitable growth continued in January–September The Group’s net sales was4.0% higher, supported by positive sales development both in the retail trade and Foodservice customers.The Group’s EBITremained stable, with an EBIT margin of 5.3%Atria Finland’s EBIT was EUR 2.4ௗmillion lower, due to the ASF-related pork export ban. ASF is estimated to reduce Atria Finland’s EBIT for 2026 by approx. EUR 4–5 million, of which approx. EUR 2 million was realisedduring the review period.Atria Sweden’sEBIT improved by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix across various distribution channels and product categories, bolstered EBIT.Atria Denmark & Estonia’sEBIT wasEUR 0.3 million higher. •Atria continued the implementation of its TOGETHER strategy bystrengthening the convenience food business in Sweden and Finland. •Energy projects that support climate targets:•Nurmon Bioenergia Oy's biogas plant was commissioned•Nurmon Bioenergia invests to start the capture of bio-based carbon dioxide•Construction of a 200 MWh energy storage project for the convenience food factory•Cross-border collaboration continues:•Gooh! pancakes from Finland to Sweden•Poultry products from Finland to Sweden•Finnish antibiotic-free chicken products under the Maks & Mooritsbrand in Estonia•In 2026, Atria Group’s adjusted EBIT is expected to be higher than in the previous year (EUR 69.9 million).•Atria's good market position, strong brands and good customer relationships, as well as reliable industrial processes, create the conditions for the positive development of EBIT also in 2026.•The ASF outbreak in Finland and other animal disease risks, the unstable European pork and beef market, cost inflation due to the Middle East crisis, and low consumer confidence in Atria's domestic markets are risk factors that may affect EBIT for the rest of the year. Future outlookAtria has continued the determined implementation of its TOGETHER 2030 strategy. THANK YOU!Financial Statement Release 2026 on 12 February 2027 29 30